| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.2 | 0.004 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |